Dupont Capital Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-577
Closed -$221K – 568
2023
Q2
$221K Buy
+577
New +$206K 0.01% 377
2022
Q4
– Sell
-427
Closed -$105K – 1539
2022
Q3
$105K Sell
427
-35
-8% -$10.7K 0.01% 1020
2022
Q2
$140K Buy
462
+45
+11% +$14.6K 0.01% 1096
2022
Q1
$171K Sell
417
-95
-19% -$37.2K 0.01% 1114
2021
Q4
$240K Sell
512
-48
-9% -$20.7K 0.01% 1070
2021
Q3
$238K Buy
+560
New +$236K 0.01% 1179
2020
Q4
– Sell
-3,633
Closed -$999K – 1421
2020
Q3
$999K Sell
3,633
-10,788
-75% -$2.85M 0.02% 511
2020
Q2
$3.28M Buy
14,421
+5,350
+59% +$1.05M 0.07% 210
2020
Q1
$1.38M Sell
9,071
-3,174
-26% -$489K 0.03% 369
2019
Q4
$1.84M Sell
12,245
-1,039
-8% -$151K 0.04% 376
2019
Q3
$1.88M Buy
13,284
+1,553
+13% +$214K 0.04% 352
2019
Q2
$1.47M Buy
11,731
+3,776
+47% +$446K 0.03% 444
2019
Q1
$877K Buy
7,955
+2,020
+34% +$210K 0.02% 585
2018
Q4
$582K Buy
+5,935
New +$644K 0.01% 683
2016
Q3
– Sell
-15,733
Closed -$1.19M – 714
2016
Q2
$1.19M Hold
15,733
– – 0.03% 406
2016
Q1
$1.09M Buy
+15,733
New +$947K 0.02% 438

Other funds holding WST

Dupont Capital Management's WST Position: Q3 2023 in Review

Dupont Capital Management sold out of West Pharmaceutical (WST) in Q3 2023, closing a stake of 577 shares — an estimated $221K sold.

Dupont Capital Management first reported a position in WST in Q1 2016 and held it in 16 quarters. The position peaked at $3.28M in Q2 2020. 757 funds tracked by Wall St. Rank hold WST as of Q3 2023.

  • Dupont Capital Management reported no remaining West Pharmaceutical position as of Q3 2023 after selling out during the quarter.
  • Dupont Capital Management sold 577 West Pharmaceutical shares in Q3 2023, an estimated $221K.
  • Dupont Capital Management first reported a position in West Pharmaceutical in Q1 2016 and held it in 16 quarters.
  • Dupont Capital Management's West Pharmaceutical position peaked at $3.28M in Q2 2020.
  • 757 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2023.

Based on Dupont Capital Management's 13F filing for Q3 2023, filed 27 Oct 2023.